Details for Patent: 9,125,939
✉ Email this page to a colleague
Which drugs does patent 9,125,939 protect, and when does it expire?
Patent 9,125,939 protects ABILIFY and ABILIFY MYCITE KIT and is included in three NDAs.
This patent has thirty-seven patent family members in twenty-six countries.
Summary for Patent: 9,125,939
| Title: | Carbostyril derivatives and mood stabilizers for treating mood disorders |
| Abstract: | The pharmaceutical composition of the present invention comprises a carbostyril derivative which is a dopamine-sero-tonin system stabilizer and a mood stabilizer in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof. The mood stabilizer may include but is not limited to lithium, valproic acid, divalproex sodium, carbamaza-pine, oxcarbamazapine, zonisamide, lamotragine, topiramate, gabapentin, levetiracetam or clonazepam. These compositions are used to treat patients with mood disorders, particularly bipolar disorder with or without psychotic features, mania or mixed episodes. Methods are provided for separate administration of a carbostyril derivative and a mood stabilizer to a patient with a mood disorder. |
| Inventor(s): | Kikuchi; Tetsuro (Tokushima, JP), Iwamoto; Taro (Princeton, NJ), Hirose; Tsuyoshi (Tokushima, JP) |
| Assignee: | Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP) |
| Application Number: | 10/556,600 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,125,939 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,125,939
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka | ABILIFY | aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 021729-002 | Jun 7, 2006 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER | ⤷ Try a Trial | ||||
| Otsuka | ABILIFY | aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 021729-003 | Jun 7, 2006 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER | ⤷ Try a Trial | ||||
| Otsuka | ABILIFY | aripiprazole | TABLET;ORAL | 021436-006 | Nov 15, 2002 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,125,939
| PCT Information | |||
| PCT Filed | May 19, 2004 | PCT Application Number: | PCT/US2004/013308 |
| PCT Publication Date: | December 09, 2004 | PCT Publication Number: | WO2004/105682 |
International Family Members for US Patent 9,125,939
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004243096 | ⤷ Try a Trial | |||
| Brazil | PI0410786 | ⤷ Try a Trial | |||
| Canada | 2526562 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
